✅ #TAVR Decision Pathway Outline
♻️2017 #ACC Expert Consensus Decision Pathway for #Transcatheter Aortic #Valve Replacement in the #Management of Adults With Aortic Stenosis
📲 https://tttttt.me/Irathero
♻️2017 #ACC Expert Consensus Decision Pathway for #Transcatheter Aortic #Valve Replacement in the #Management of Adults With Aortic Stenosis
📲 https://tttttt.me/Irathero
Forwarded from اتچ بات
📚 به روز رسانی #اطلاعات 📕📖
📚 #دانلود #مقاله 📚📖
💻👉👉#DOWNLOAD PDF:
✅ ❣️ACC 2018 : #TAVR for Severe Bicuspid #Aortic #Valve Stenosis❣️
📌Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients with symptomatic severe aortic valve stenosis (AS). Although randomized trials have established TAVR as the standard treatment in inoperable patients and a reasonable option in intermediate- or high-surgical-risk patients, bicuspid AS has been excluded from these major trials.1-4 This was mainly attributable to concerns about challenging anatomic features of bicuspid AS for TAVR including the following:
1. A larger annulus, severe and asymmetric leaflet calcification, or presence of calcified raphe that may hinder valve positioning and expansion and lead to significant paravalvular regurgitation or annulus rupture (Figure 1)
2. Concomitant aortopathy with a potential increased risk of aortic dissection or rupture during long-term follow-up
3. Long-term durability of transcatheter heart valves in younger patients with longer life expectancy
💛 #دانلود کامل #مقاله در فرمت PDF 👇👇👇
💻 https://goo.gl/vrU26S
✨ Join Us✨
📲 @IRathero💫
📚 #دانلود #مقاله 📚📖
💻👉👉#DOWNLOAD PDF:
✅ ❣️ACC 2018 : #TAVR for Severe Bicuspid #Aortic #Valve Stenosis❣️
📌Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients with symptomatic severe aortic valve stenosis (AS). Although randomized trials have established TAVR as the standard treatment in inoperable patients and a reasonable option in intermediate- or high-surgical-risk patients, bicuspid AS has been excluded from these major trials.1-4 This was mainly attributable to concerns about challenging anatomic features of bicuspid AS for TAVR including the following:
1. A larger annulus, severe and asymmetric leaflet calcification, or presence of calcified raphe that may hinder valve positioning and expansion and lead to significant paravalvular regurgitation or annulus rupture (Figure 1)
2. Concomitant aortopathy with a potential increased risk of aortic dissection or rupture during long-term follow-up
3. Long-term durability of transcatheter heart valves in younger patients with longer life expectancy
💛 #دانلود کامل #مقاله در فرمت PDF 👇👇👇
💻 https://goo.gl/vrU26S
✨ Join Us✨
📲 @IRathero💫
Telegram
attach 📎
Forwarded from اتچ بات
📚 به روز رسانی #اطلاعات 📕📖
📚 #دانلود #مقاله 📚📖
💻👉👉#DOWNLOAD PDF:
✅ ❣️ACC 2018 : #TAVR for Severe Bicuspid #Aortic #Valve Stenosis❣️
📌Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients with symptomatic severe aortic valve stenosis (AS). Although randomized trials have established TAVR as the standard treatment in inoperable patients and a reasonable option in intermediate- or high-surgical-risk patients, bicuspid AS has been excluded from these major trials.1-4 This was mainly attributable to concerns about challenging anatomic features of bicuspid AS for TAVR including the following:
1. A larger annulus, severe and asymmetric leaflet calcification, or presence of calcified raphe that may hinder valve positioning and expansion and lead to significant paravalvular regurgitation or annulus rupture (Figure 1)
2. Concomitant aortopathy with a potential increased risk of aortic dissection or rupture during long-term follow-up
3. Long-term durability of transcatheter heart valves in younger patients with longer life expectancy
💛 #دانلود کامل #مقاله در فرمت PDF 👇👇👇
💻 https://goo.gl/vrU26S
✨ Join Us✨
📲 @IRathero💫
📚 #دانلود #مقاله 📚📖
💻👉👉#DOWNLOAD PDF:
✅ ❣️ACC 2018 : #TAVR for Severe Bicuspid #Aortic #Valve Stenosis❣️
📌Transcatheter aortic valve replacement (TAVR) has evolved from a novel technology to an established therapy for high-risk patients with symptomatic severe aortic valve stenosis (AS). Although randomized trials have established TAVR as the standard treatment in inoperable patients and a reasonable option in intermediate- or high-surgical-risk patients, bicuspid AS has been excluded from these major trials.1-4 This was mainly attributable to concerns about challenging anatomic features of bicuspid AS for TAVR including the following:
1. A larger annulus, severe and asymmetric leaflet calcification, or presence of calcified raphe that may hinder valve positioning and expansion and lead to significant paravalvular regurgitation or annulus rupture (Figure 1)
2. Concomitant aortopathy with a potential increased risk of aortic dissection or rupture during long-term follow-up
3. Long-term durability of transcatheter heart valves in younger patients with longer life expectancy
💛 #دانلود کامل #مقاله در فرمت PDF 👇👇👇
💻 https://goo.gl/vrU26S
✨ Join Us✨
📲 @IRathero💫
Telegram
attach 📎